StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
GoodRx Holdings Inc. (GDRX) PT Lowered to $20 at JPMorgan
March 1, 2022 4:58 AM
JPMorgan analyst Doug Anmuth lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $20.00 (from $33.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
GoodRx Holdings Inc. (GDRX) PT Lowered to $30 at Goldman Sachs
March 1, 2022 6:58 AM
GoodRx Holdings (GDRX) Shares Crash 30% After Earnings and Guidance Miss, Prompting Several Downgrades
March 1, 2022 6:21 AM
UPDATE: GoodRx Holdings Inc. (GDRX) PT Lowered to $28 at Evercore ISI
March 1, 2022 4:32 AM
UPDATE: Credit Suisse Downgrades GoodRx Holdings Inc. (GDRX) to Neutral
March 1, 2022 3:57 AM
After-Hours Stock Movers 02/28: (DDD) (ACI) (WDAY) Higher; (GDRX) (AMBA) (LCID) Lower (more...)
February 28, 2022 6:03 PM
GoodRx (GDRX) Shares Down 28% on Q4 Miss, Weak Outlook
February 28, 2022 5:31 PM
Form 8-K GoodRx Holdings, Inc. For: Feb 28
February 28, 2022 4:30 PM
Form 8-K GoodRx Holdings, Inc. For: Feb 28
February 28, 2022 4:17 PM
GoodRx Holdings, Inc. (GDRX) Misses Q4 EPS by 1c; Guides Q1 Revs Below the Street
February 28, 2022 4:13 PM
GoodRx Holdings, Inc. (GDRX) Announces $250M Share Buyback
February 28, 2022 4:10 PM
GoodRx Holdings, Inc. (GDRX) Announces $250M Share Buyback
February 28, 2022 4:10 PM
GoodRx Announces $250 Million Share Repurchase Program
February 28, 2022 4:07 PM
GoodRx Releases Fourth Quarter and Full Year 2021 Financial Results
February 28, 2022 4:07 PM
